The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Babak S.L.

Russian University of Medicine

Gurov A.V.

N.I. Pirogov Russian National Research Medical University

Zhuravleva M.V.

I.M. Sechenov First Moscow State Medical University (Sechenovskiy University)

Leshchenko I.V.

Ural State Medical University of the Ministry of the Healthcare of the Russian Federation

Sinopalnikov A.I.

Russian Medical Academy of Continuous Professional Education under The Ministry of Health of the Russian Federation

The many faces of cough: resolution of the Expert Council of the Russian Scientific Medical Society of Therapists

Authors:

Malyavin A.G., Babak S.L., Gurov A.V., Zhuravleva M.V., Leshchenko I.V., Sinopalnikov A.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(9): 82‑92

DOI: 10.17116/profmed20242709182

Read: 1618 times

Download PDF (RU)
Contact the author
Table of contents

THE MANY FACES OF COUGH: RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS
THE MANY FACES OF COUGH: RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS

To cite this article:

Malyavin AG, Babak SL, Gurov AV, Zhuravleva MV, Leshchenko IV, Sinopalnikov AI. The many faces of cough: resolution of the Expert Council of the Russian Scientific Medical Society of Therapists. Russian Journal of Preventive Medicine. 2024;27(9):82‑92. (In Russ.)
https://doi.org/10.17116/profmed20242709182

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cough diagnosis: from origins to modern times (review of lite­rature). Journal of Respiratory Medi­cine. 2025;(1):38-42
Acute bronchitis: to treat or not to treat?. Journal of Respiratory Medi­cine. 2025;(1):49-57
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18
Clinical features of ulce­rative lary­ngitis. Russian Bulletin of Otorhinolaryngology. 2025;(2):20-25
Abstract:

The meeting of the Expert Council of the Russian Scientific Medical Society of Therapists held in February 2024 on the topic of «The Many Faces of Cough» emphasized the role of differential diagnostics of cough as a symptom of inflammatory diseases of the respiratory tract, allergic diseases, and other pathological conditions. The experts have outlined the role and place of herbal and synthetic medicines (antitussants, mucoactive drugs, expectorants, and combination drugs for the treatment of cough) in certain clinical situations and determined the indications for fixed drug combinations.

Keywords:

cough
differential diagnostics of cough
antitussants
mucoactive drugs
expectorants
combination drugs for treating cough

Authors:

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Babak S.L.

Russian University of Medicine

Gurov A.V.

N.I. Pirogov Russian National Research Medical University

Zhuravleva M.V.

I.M. Sechenov First Moscow State Medical University (Sechenovskiy University)

Leshchenko I.V.

Ural State Medical University of the Ministry of the Healthcare of the Russian Federation

Sinopalnikov A.I.

Russian Medical Academy of Continuous Professional Education under The Ministry of Health of the Russian Federation

Received:

16.07.2024

Accepted:

05.08.2024

Close metadata

References:

  1. Finley CR, Chan DS, Garrison S, et al. What are the most common conditions in primary care? Systematic review. Canadian Family Physician. 2018; 64(11):832-840. 
  2. Morice AH. Epidemiology of cough. Pulmonary Pharmacology and Therapeutics. 2002;15(3):253-259.  https://doi.org/10.1006/pupt.2002.0352
  3. Burns SA, Smirnova MI. A patient with a cough at an appointment with a general practitioner: step-by-step instructions for diagnosis and treatment. Terapija. 2024;10(2):121-132. (In Russ.). https://doi.org/10.18565/therapy.2024.2.121-132
  4. Klinicheskie rekomendacii. Xronicheskij bronxit. ID: 655. 2021. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed August 07, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/655_1
  5. Barbee RA, Halonen M, Kaltenborn WT, et al. A longitudinal study of respiratory symptoms in a community population sample. Correlations with smoking, allergen skin-test reactivity, and serum IgE. Chest. 1991;99(1):20-26.  https://doi.org/10.1378/chest.99.1.20
  6. McGarvey LP, Heaney LG, Lawson JT, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998;53(9):738-743. 
  7. Irwin RS, French CL, Chang AB, et al. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest. 2018;153(1):196-209.  https://doi.org/10.1016/j.chest.2017.10.016
  8. Brink AJ, Van Wyk J, Moodley VM, et al. The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. South African Medical Journal. 2016;106(6):554-561.  https://doi.org/10.7196/SAMJ.2016.v106i6.10857
  9. Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs. Chest. 1994;106(5):1532-1537. https://doi.org/10.1378/chest.106.5.1532
  10. Zaitsev AA, Sinopalnikov AI. Management of adult patients with bronchiectasis (based on the recommendations of the European Respiratory Society). Prakticheskaja pul’monologija. 2018;4:36-54. (In Russ.).
  11. Zaitsev AA, Belotserkovskaya YuG. Mucoactive and antitussive therapy for acute respiratory diseases in real clinical practice. Prakticheskaja pul’monologija. 2021;2:75-80. (In Russ.). https://doi.org/10.24412/2409-6636-2021-12694
  12. Soilemezi D, Leydon GM, Yan R, et al. Herbal medicine for acute bronchitis: A qualitative interview study of patients’ and health professionals’ views. Complementary Therapies in Medicine. 2020;55:102613. https://doi.org/10.1016/j.ctim.2020.102613
  13. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittel-Forschung. 2007;57(9):607-615.  https://doi.org/10.1055/s-0031-1296656
  14. Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittel-Forschung. 2006; 56(9):652-660.  https://doi.org/10.1055/s-0031-1296767
  15. Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011;18(13):1105-1109. https://doi.org/10.1016/j.phymed.2011.06.014
  16. Kurth W. Gesicherte therapeutische Wirksamkeit des traditionellen Antitussivums Mintetten im Doppelblindversuch. Die Medizinische Welt. 1978;29: 1906-1909.
  17. Wagner L, Cramer H, Klose P, et al. Herbal Medicine for Cough: a Systematic Review and Meta-Analysis. Forschende Komplementarmedizin. 2015; 22(6):359-368. 
  18. Ismail C, Miller G, Steindl H. Bronchipret and synthetic mucolytics in acute bronchitis: a comparative cohort study. Farmateka. 2005;19:86-90. (In Russ.).
  19. Klinicheskie rekomendacii. Bronxit. ID: 381. 2021. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed August 07, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/381_2
  20. Rossijskoe respiratornoe obshhestvo, Rossijskoe nauchnoe medicinskoe obshhestvo terapevtov, Mezhregional`naya associaciya specialistov respiratornoj mediciny`. Proekt klinicheskix rekomendacij. Ostry`j bronxit u vzrosly`x. Accessed May 14, 2024. (In Russ.). https://www.rnmot.ru/public/uploads/2022/rnmot/Acute%20bronchite.pdf
  21. Okovity SV, Maryushkina VS, Sukhanov DS, et al. Pharmacological approaches to the rational choice of combined mucoactive drugs. Lechashhij vrach. 2020;12(23):41-45. (In Russ.). https://doi.org/10.26295/OS.2020.95.33.009
  22. Lidzhieva AA, Smolyarchuk EA. Levosalbutamol — new treatment options for bronchial asthma. Vedomosti Nauchnogo centra jekspertizy sredstv medicinskogo primenenija. 2015;2:25-28. (In Russ.).
  23. Miroshnichenko AG, Bulgakova YS, Perfiliev VY, et al. Levosalbutamol as alternative to drugs on the basis of racemic salbutamol: Review of the results of pre-clinical research. Regulatory Mechanisms in Biosystems. 2017;8(4): 583-595. 
  24. Zaitsev AA, Leshchenko IV, Esaulova NA, et al. Evaluation of the efficacy and safety of a combined drug containing ambroxol, guaifenesin and levosalbutamol in comparison with a fixed combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis. Terapevticheskij arhiv. 2023;95(3):235-241. (In Russ.).
  25. Naqvi KF, Mazzone SB, Shiloh MU. Infectious and Inflammatory Pathways to Cough. Annual review of physiology. 2023;85:71-91.  https://doi.org/10.1146/annurev-physiol-031422-092315
  26. Panyakina MA, Ovchinnikov AY. Cough with acute respiratory viral infections. The view of an otorhinolaryngologist on the possibilities of modern pharmacotherapy. RMZH. 2012;28:1402. (In Russ.).
  27. Klinicheskie rekomendacii. Ostry`e respiratorny`e virusny`e infekcii (ORVI) u vzrosly`x. ID: 724. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. 2021. Accessed May 14, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/724_1
  28. Knyazheskaya NP. Journal for continuous medical education of doctors. Combined expectorant drugs in the practice of an internist. Features of the preparations Kodelak Broncho and Kodelak Broncho with thyme. Spravochnik poliklinicheskogo vracha. 2012;11:45-49. (In Russ.).
  29. Snegotskaya MN, Malakhov AB, Kolosova NG. New drugs in the treatment of cough in children. Jeffektivnaja farmakoterapija. Pediatrija. 2012;5:24-28. (In Russ.).
  30. Anaev EH. Mucolytic therapy: a rational choice. Effective pharmacotherapy. Pul’monologija i otorinolaringologija. 2010;2:25-28. (In Russ.).
  31. Knyazheskaya NP. The use of ambroxol in the treatment of respiratory diseases. Farmateka. 2014;3:76-80. (In Russ.).
  32. Babak SL, Gorbunova MV, Malyavin AG. Safety of ambroxol in the treatment of respiratory diseases in adults. Prakticheskaja pul’monologija. 2019; 1:84-90. (In Russ.).
  33. Tolstikov GA, Baltina LA. Glycyrrhizic acid. Bioorganicheskaja himija. 1997; 23(9):691-709. (In Russ.).
  34. Kolesnichenko PD, Peresypkina AA, Poromov AA, et al. Study to Investigate the anti-inflammatory effect of Codelac® Broncho with Thymus Serpyllum (elixir) in comparison with reference drug Fenspiride (syrup) using accute Carrageenan-induced Paw Inflammation Model. Research Results in Pharmacology. 2019;5(1):45-52.  https://doi.org/10.3897/rrpharmacology.5.33233
  35. Yanagawa Y, Ogura M, Fujimoto E, et al. Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day treatment assignment clinical trial. Current Therapeutic Research, Clinical and Experimental. 2004;65(1):26-33.  https://doi.org/10.1016/S0011-393X(04)90002-1
  36. Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytotherapy research: PTR. 2008;22(2):141-148.  https://doi.org/10.1002/ptr.2295
  37. Sokolov SYa. Fitoterapiya i fitofarmakologiya: Rukovodstvo dlya vrachej. M.: Medicinskoe informacionnoe agentstvo; 2000. (In Russ.).
  38. Chen EY, Yang N, Quinton PM, et al. A new role for bicarbonate in mucus formation. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2010;299(4):L542-549.  https://doi.org/10.1152/ajplung.00180.2010
  39. Gróf I, Bocsik A, Harazin A, et al. The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel. International Journal of Molecular Sciences. 2020;21(11):4024. https://doi.org/10.3390/ijms21114024
  40. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatric Pulmonology. 2010;45(1):36-40.  https://doi.org/10.1002/ppul.21185
  41. Angoulvant F, Bellêttre X, Milcent K, et al; Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group. Effect of Nebulized Hypertonic Saline Treatment in Emergency Departments on the Hospitalization Rate for Acute Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatrics. 2017;171(8):e171333. https://doi.org/10.1001/jamapediatrics.2017.1333
  42. Huijghebaert S, Hoste L, Vanham G. Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19. European Journal of Clinical Pharmacology. 2021;77(9):1275-1293. https://doi.org/10.1007/s00228-021-03102-3
  43. Reeves EP, Williamson M, O’Neill SJ, Greally P, McElvaney NG. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011; 183(11):1517-1523. https://doi.org/10.1164/rccm.201101-0072OC
  44. Zaitsev AA, Kulikova NA, Filon EA, et al. Clinical efficacy of mucoactive therapy with 7% hypertensive solution in patients with acute bronchitis. Medicinskij sovet. 2022;(23):136-141. (In Russ.). https://doi.org/10.21518/2079-701X-2022-16-23-136-141
  45. Denisov AR, Kolosova NG, Grebeneva IV, et al. The use of hypertensive solution in children with acute bronchitis. Medicinskij sovet. 2021;(17):78-84. (In Russ.). https://doi.org/10.21518/2079-701X-2021-17-78-84
  46. Instruction for medical use of the drug Sinecod LP-No.(003493)-(RG-RU), 25.10.2023.
  47. Materazzi F, Capano R, D’Urso B, et al. Note terapeutiche sul butamirato citrato. Gazzetta Medica Italiana. 1984;143(4):229–223. 
  48. Instruction for medical use of the solution Sinecod LP-No.(004125)-(RG-RU), 22.12.2023.
  49. Nikiforova GN. Synecode — the drug of choice for the treatment of dry cough in children and adults. RMZH. 2011;23:1436-1438. (In Russ.).
  50. Kotlukov VK, Kazakova TV, Antipova NV. Therapy of cough syndrome in respiratory infections in children. Medicinskij sovet. 2017;19:102-103. (In Russ.). https://doi.org/10.21518/2079-701X-2017-19-102-103
  51. Płusa T. Miejsce cytrynianu butamiratu w kontrolowaniu kaszlu w zapaleniu dróg oddechowych [Butamirate citrate in control of cough in respiratory tract inflammation]. Polski Merkuriusz Lekarski. 2017;43(254):69-74. 
  52. Avdeev SN, Garashchenko TI, Geppe NA, et al. Official statements of the board of experts on the use of topical thiamphenicol in patients with communityacquired respiratory infections. Clinical Microbiology and Antimicrobial Chemotherapy. 2021;23(2):195-196. (In Russ.). https://doi.org/10.36488/cmac.2021.2.195-196
  53. Samuni Y, Goldstein S, Dean OM, et al. The chemistry and biological activities of N-acetylcysteine. Biochimica et Biophysica Acta. 2013;1830(8): 4117-4129. https://doi.org/10.1016/j.bbagen.2013.04.016
  54. Dinicola S, De Grazia S, Carlomagno G, et al. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. European Review for Medical and Pharmacological Sciences. 2014;18(19):2942-2948.
  55. Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. Respiratory Medicine. 2016;117:190-197.  https://doi.org/10.1016/j.rmed.2016.06.015
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.